Results 201 to 210 of about 102,708 (355)

Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta‐Analysis

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Statin therapy in cirrhosis may confer a survival benefit while reducing the risk of hepatic decompensation and hepatocellular carcinoma. ABSTRACT Background The role of statins in cirrhosis remains controversial. Historically restricted due to safety concerns, emerging evidence highlights potential pleiotropic benefits, though effects on mortality and
Bernardo de Faria Moraes   +8 more
wiley   +1 more source

A Patient with E. coli-induced Pyelonephritis and Sepsis Who Transiently Exhibited Symptoms Associated with Primary Biliary Cirrhosis

open access: bronze, 2003
Nobuhiko Ohno   +7 more
openalex   +2 more sources

Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis [PDF]

open access: bronze, 1996
Kevin P. Rioux   +3 more
openalex   +1 more source

PRIMARY BILIARY CIRRHOSIS

open access: yesMedicine, 1950
E H, AHRENS   +4 more
openaire   +2 more sources

The Alpha‐1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Alpha‐1 antitrypsin deficiency is a genetic disease that affects the lungs and the liver. The role of the heterozygous genetic defect in the development of liver cancer in patients with cirrhosis is unclear. Our study found that carrying the Pi*MZ genotype increases the risk of developing liver cancer.
Lorenz Balcar   +18 more
wiley   +1 more source

Development of NAFLD‐Specific Human Liver Organoid Models on a Microengineered Array Chip for Semaglutide Efficacy Evaluation

open access: yesCell Proliferation, EarlyView.
Microporous array organ chips were integrated with commercially available well plates to develop organoid chip platforms, which enable modelling of hepatic physiology and non‐alcoholic fatty liver disease (NAFLD) pathogenesis, as well as evaluation of semaglutide therapeutics. ABSTRACT Progressive non‐alcoholic fatty liver disease (NAFLD) may culminate
Xiao‐yan You   +3 more
wiley   +1 more source

Chronic hepatitis in horses with persistent equine hepacivirus infection

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Equine hepacivirus (EqHV) is closely related to hepatitis C virus (HCV), which causes persistent infection and chronic hepatitis in people. Information on persistent EqHV infection and hepatitis is limited. Objectives To report 19 cases of chronic hepatitis and persistent EqHV infection.
Mason C. Jager   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy